MEDTRONIC PLCDL-.0001 news, videos and press releases - Page 2
For more news please use our advanced search feature.
MEDTRONIC PLCDL-.0001 - More news...
MEDTRONIC PLCDL-.0001 - More news...
- Medtronic: Building a More Sustainable Future
- TMCF and Medtronic Partner To Launch Academic R&D Grants at HBCUs
- Medtronic LABS Unveils Commitment To Scale Tech-Enabled Healthcare at Clinton Global Initiative 2023 Meeting
- Medtronic Foundation: 3 Ways To Transform Corporate Volunteering
- Over 3.3M Meals Packed by Medtronic Employee Volunteers
- Medtronic Mobile Labs Head to College
- Medtronic: How Lake Geneva Helps Heat and Cool a European Manufacturing Site
- Medtronic Recognized as a "Best Place To Work for Disability Inclusion"
- Medtronic: By the Community, for the Community
- Recipe for Bonding: Paid Leave Gives New Dad Needed Time
- Everstream Analytics & Medtronic Recognized by Supply & Demand Chain Executive
- Medtronic Designated as a "3+" Company in the 50/50 Women on Boards Gender Diversity Directory(TM)
- How One Leader Is Aiming Higher To Increase Asian American Representation
- Medtronic Jumps to No. 2 in DiversityInc Top 50 Companies List
- New Leadership Reinforces Medtronic Foundation's Commitment To ID&E
- Medtronic Named as a Leading Sustainability Company
- Medtronic Podcast: Krista Sugerman Explains How Medtronic Is Developing New Innovative Technology To Make Its Fight Against Diabetes Is Personal
- How Technology Helps Remove Barriers to Equity in the Workplace
- INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Medtronic plc with Losses of $100,000 to Contact the Firm
- Medtronic Cryoablation Superior to Drug Therapy for Symptomatic Paroxysmal Atrial Fibrillation
- Medtronic Reports First Quarter Financial Results
- Medtronic Board Appoints Kevin Lofton as a New Director
- Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2021
- Medtronic Evolut TAVR System Receives Updated U.S. Labeling Revising Precaution for Treatment of Low-Risk Patients with Bicuspid Aortic Stenosis
- Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System
- Study Published in The New England Journal of Medicine Demonstrates Patients Experience Fewer Disruptions to Dialysis Therapy When Treated with Medtronic Drug-Coated Balloon
- Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2021
- Medtronic to Acquire Smart Insulin Pen Company Companion Medical
- Medtronic Announces Comprehensive U.S. Launch of New InterStim™ Micro Neurostimulator
- Medtronic Expands Leadership in Treating Bladder and Bowel Control Conditions with Two New FDA-Approved Products: InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads
